Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Palantir Technologies Inc. (PLTR)

2026-06-24T18:38:05.847344+00:00

Key Updates

Palantir Technologies (PLTR) has extended its sequential decline, falling 4.74% since the June 23 report to $113.70 and confirming the breakdown below the $120 psychological level. The uninterrupted selling pressure deepens the six-month drawdown to 41.44% and fully invalidates the $130-$160 consolidation thesis referenced in prior coverage. No new fundamental catalysts have emerged to arrest the downtrend, leaving prevailing valuation and political risk concerns as the dominant market drivers.

Current Trend

The trend is decisively bearish across all measured timeframes. Year-to-date performance stands at -36.03%, with the six-month decline at -41.44%, the one-month decline at -16.93%, and the five-day decline at -14.67%. The stock has collapsed through the $130 support zone identified in reports dated June 18-23 and has now violated the $120 level. Price action indicates accelerating momentum to the downside, with each successive session extending losses. The absence of any referenced support level below $113.70 in the provided data leaves the trajectory open-ended.

Investment Thesis

The investment thesis has shifted fully bearish. While the company retains strong underlying economics—including approximately 80% gross margins, positive free cash flow, and an AIP-driven enterprise sales cycle compressed to under five days—these fundamentals are currently overwhelmed by valuation concerns and political risk. The stock’s $375 billion valuation, cited in early June coverage, remains incompatible with the current price trajectory in the eyes of prominent short sellers. Government contract concentration, which underpins the revenue base across defense, healthcare, and intelligence, now constitutes a liability amid escalating UK political opposition and blocked deals. The CHIPS Act exposure offers a longer-term revenue avenue but does not provide near-term price support.

Thesis Status

The bullish thesis is invalidated. The $130-$160 consolidation range cited on May 29 has broken down completely, and the $130 support has converted to formidable resistance. The bearish thesis initiated with the June 18 breakdown below $130 is now active and intensifying. Risk management has deteriorated: with no identifiable support levels in the provided data beneath $113.70, downside containment relies on external factors not present in the current dataset. The opportunity profile for long positions remains unfavorable until technical stabilization is observed.

Key Drivers

Several factors are directing price action. First, valuation skepticism from institutional investors, including a disclosed short position by Michael Burry arguing massive overvaluation, weighs on sentiment (The Guardian). Second, political and contract risk in the UK has intensified: the London mayor blocked a £50 million Metropolitan Police deal, nearly 250,000 petitioners oppose state contracts, and MPs have raised data sovereignty concerns, threatening approximately £600 million in UK revenue (The Guardian). Third, fundamental strengths persist but are discounted, including 80% gross margins, positive free cash flow, and sub-five-day AIP bootcamp sales cycles (CNBC). Fourth, potential upside from over $2 billion in CHIPS Act federal spending on deep-tech infrastructure remains a structural tailwind (CNBC). Fifth, the company’s dual Government and Commercial segment structure exposes it to concentrated regulatory and political headline risk (Forbes).

Technical Analysis

PLTR is trading at $113.70, having fallen through successive support tiers. The $130 level, which contained the June 12 rebound, was decisively broken on June 18 and now acts as distant resistance. The intermediate $120 level has also failed. The 5-day decline of 14.67% and the single-session drop of 2.57% confirm sustained selling pressure. The CNBC-cited $130-$160 range is now a bearish reference zone overhead. No support levels are identified in the provided data below the current price, leaving the stock vulnerable to further downside discovery until a concrete floor is established.

Bull Case

  • Superior unit economics: The company maintains approximately 80% gross margins and positive free cash flow, providing durable operational leverage and balance sheet flexibility (CNBC).
  • AIP-driven velocity: The AI Platform bootcamp strategy has compressed the enterprise sales cycle to under five days, materially improving commercial scalability and time-to-revenue (CNBC).
  • Federal infrastructure tailwind: Palantir is positioned to capture spending from over $2 billion in CHIPS Act allocations for domestic deep-tech infrastructure, anchoring future government revenue (CNBC).
  • Established UK revenue base: UK government contracts across the NHS, Ministry of Defence, and police forces are valued at approximately £600 million, reflecting deep institutional entrenchment (The Guardian).
  • Sector diversification: The platform serves multiple verticals including defense, intelligence, healthcare, energy, and financial services, mitigating single-industry concentration (Forbes).

Bear Case

  • Extreme valuation vulnerability: The company is valued at $375 billion, and prominent investor Michael Burry has taken a short position based on a thesis of massive overvaluation, a concern underscored by the 41% six-month price decline (The Guardian).
  • Active political erosion of revenue: The London mayor blocked a £50 million Metropolitan Police contract, while nearly 250,000 petitioners and multiple MPs oppose Palantir’s UK state role, directly threatening the approximately £600 million UK contract portfolio (The Guardian).
  • Government concentration risk: The Government segment constitutes a core revenue pillar, exposing Palantir to sovereign data-sovereignty disputes, regulatory intervention, and shifting political sentiment across US and international agencies (Forbes).
  • Fundamental discounting by the market: Despite strong gross margins and positive free cash flow, the market is repricing the stock aggressively lower, indicating that operational strengths are currently insufficient to offset valuation and political concerns (CNBC).
  • Accelerating technical deterioration: The 5-day decline of 14.67% and the break below the $130-$160 consolidation range confirm sustained institutional selling and the absence of near-term demand at higher levels (CNBC).

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.